Smart pens reveal how often diabetics skip insulin shots—and what it costs

A new study using connected insulin pens found that many adults with type 1 diabetes miss basal insulin doses far more often than they realize, directly harming their blood sugar control. The finding could reshape how insurers, device makers, and healthcare providers approach adherence monitoring and patient support.

Originaltitel: Smart Pen Exposes Missed Basal Insulin Injections and Reveals the Impact on Glycemic Control in Adults With Type 1 Diabetes